Zhang Wangyang, Zhao Chaoshan, Jia Haoliang, Liu Tao, Yang Jiaqian, Wu Pengfan, Mu Xiaojing
Key Laboratory of Optoelectronic Technology and Systems, Ministry of Education and International Research and Development Center of Micro-Nano Systems and New Materials Technology, Chongqing University, Chongqing, 400044, China.
Microsyst Nanoeng. 2024 Dec 5;10(1):182. doi: 10.1038/s41378-024-00808-z.
Ultrasonic biochemical detection is important for biomarker detection, drug monitoring, and medical diagnosis, as it can predict disease progression and enable effective measures to be taken in a timely manner. However, the ultrasonic technology currently used for biochemical marker detection is directly modified on the surface of the device. The associated test methods are costly and unreliable while having poor repeatability; therefore, they cannot achieve low-cost rapid testing. In this study, a detection mechanism based on the Rayleigh scattering of acoustic waves caused by nanoparticles, which causes changes in the received sound pressure, was developed for the first time. The modification of antibodies on an insertable substrate decouples the functionalization step from the sensor surface and facilitates the application of capacitive micromachined ultrasonic transducers (CMUTs) in conjunction with Au nanoparticles (AuNPs) for CA19-9 cancer antigen detection. A corresponding detection theory was established, and the relevant parameters of the theoretical formula were verified using different nanoparticles. Using our fabricated CMUT chip with a resonant frequency of 1 MHz, the concentrations and substances of the CA19-9 antigen markers were successfully measured. In the concentration range of 0.1-1000 U/mL, the receiving voltage decreased with increasing concentration. Further investigations revealed that the influence of other interfering markers in the human body can be ignored, demonstrating the feasibility and robustness of biochemical detection based on CMUTs combined with nanoparticles.
超声生化检测对于生物标志物检测、药物监测和医学诊断至关重要,因为它可以预测疾病进展并能够及时采取有效措施。然而,目前用于生化标志物检测的超声技术是在设备表面直接进行修饰。相关测试方法成本高昂且不可靠,同时重复性较差;因此,它们无法实现低成本快速检测。在本研究中,首次开发了一种基于纳米颗粒引起的声波瑞利散射导致接收声压变化的检测机制。在可插入基板上修饰抗体,使功能化步骤与传感器表面分离,并便于将电容式微机械超声换能器(CMUT)与金纳米颗粒(AuNP)结合用于CA19-9癌抗原检测。建立了相应的检测理论,并使用不同的纳米颗粒验证了理论公式的相关参数。使用我们制造的共振频率为1 MHz的CMUT芯片,成功测量了CA19-9抗原标志物的浓度和物质。在0.1-1000 U/mL的浓度范围内,接收电压随浓度增加而降低。进一步研究表明,人体中其他干扰标志物的影响可以忽略不计,这证明了基于CMUT与纳米颗粒结合的生化检测的可行性和稳健性。